These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 17911631)
1. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. Baritaki S; Katsman A; Chatterjee D; Yeung KC; Spandidos DA; Bonavida B J Immunol; 2007 Oct; 179(8):5441-53. PubMed ID: 17911631 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells. Baritaki S; Suzuki E; Umezawa K; Spandidos DA; Berenson J; Daniels TR; Penichet ML; Jazirehi AR; Palladino M; Bonavida B J Immunol; 2008 May; 180(9):6199-210. PubMed ID: 18424742 [TBL] [Abstract][Full Text] [Related]
3. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Huerta-Yepez S; Vega M; Escoto-Chavez SE; Murdock B; Sakai T; Baritaki S; Bonavida B Nitric Oxide; 2009 Feb; 20(1):39-52. PubMed ID: 18778787 [TBL] [Abstract][Full Text] [Related]
4. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S; Vega M; Garban H; Bonavida B Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1. Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117 [TBL] [Abstract][Full Text] [Related]
6. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry. Bonavida B; Baritaki S Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602 [TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer. Wottrich S; Kaufhold S; Chrysos E; Zoras O; Baritaki S; Bonavida B Drug Resist Updat; 2017 Jan; 30():28-38. PubMed ID: 28363333 [TBL] [Abstract][Full Text] [Related]
8. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP; Zisman A; Bonavida B Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140 [TBL] [Abstract][Full Text] [Related]
9. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. Baritaki S; Yeung K; Palladino M; Berenson J; Bonavida B Cancer Res; 2009 Nov; 69(21):8376-85. PubMed ID: 19843864 [TBL] [Abstract][Full Text] [Related]
10. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis. Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568 [TBL] [Abstract][Full Text] [Related]
11. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022 [TBL] [Abstract][Full Text] [Related]
12. Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis. Martínez-Paniagua MA; Baritaki S; Huerta-Yepez S; Ortiz-Navarrete VF; González-Bonilla C; Bonavida B; Vega MI Cell Cycle; 2011 Aug; 10(16):2792-805. PubMed ID: 21822052 [TBL] [Abstract][Full Text] [Related]
13. A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells. Vega MI; Baritaki S; Huerta-Yepez S; Martinez-Paniagua MA; Bonavida B Leuk Lymphoma; 2011 Jan; 52(1):108-21. PubMed ID: 21133714 [TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. Bonavida B; Baritaki S; Huerta-Yepez S; Vega MI; Chatterjee D; Yeung K Nitric Oxide; 2008 Sep; 19(2):152-7. PubMed ID: 18477483 [TBL] [Abstract][Full Text] [Related]
15. BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma. Ishii Y; Kolluri KK; Pennycuick A; Zhang X; Nigro E; Alrifai D; Borg E; Falzon M; Shah K; Kumar N; Janes SM J Biol Chem; 2021 Nov; 297(5):101223. PubMed ID: 34597666 [TBL] [Abstract][Full Text] [Related]
16. Viral infection and cancer: the NF-kappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes. Baritaki S; Bonavida B Crit Rev Immunol; 2010; 30(1):31-46. PubMed ID: 20370618 [TBL] [Abstract][Full Text] [Related]
17. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
18. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. Kang J; Bu J; Hao Y; Chen F Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917 [TBL] [Abstract][Full Text] [Related]
19. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836 [TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation. Chen JJ; Chou CW; Chang YF; Chen CC J Immunol; 2008 Jun; 180(12):8030-9. PubMed ID: 18523266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]